NONMEM Users Network Archive

Hosted by Cognigen

Rosenön Meeting 2009: DMPK Aspects of Drug Combinations

From: Erik Ahlzén <erik.ahlzen>
Date: Fri, 24 Apr 2009 15:45:48 +0200

Rosenn Meeting 2009: DMPK Aspects of Drug Combinations =

September 17-19, 2009

Stockholm, Sweden


This year's meeting will deal with various aspects of drug combinations =
both from a preclinical and clinical point of view. We will discuss =
methods to identify and predict clinical relevant drug-drug =
interactions. We will also look into PK/PD aspects of drug combinations =
as well as pharmacogenetic implications for certain patient groups. In =
addition we will debate regulatory aspects of drug combinations.



Michel Eichelbaum, Dr. Margarete Fischer-Bosch - IKP, Kim Brouwer, =
University of North Carolina, Heyo Kroemer, Ernst Moritz Arndt =
University of Greifswald, Magnus Ingelman-Sundberg, Karolinska =
Institutet, Johan Gabrielsson, AstraZeneca R&D Mlndal, Kuresh Youdim, =
Pfizer Global R&D, Sandwich, Thomas Bouillon, Novartis Pharma, Ulf =
Diczfalusy, Karolinska University Hospital, Mikko Niemi, University of =
Helsinki, Ylva Bttiger, Karolinska University Hospital, Erik =
Eliasson, Karolinska University Hospital, Filip Josephson, Karolinska =
University Hospital, Qun-Ying Yue, The Medical Products Agency, Monica =
Edholm, The Medical Products Agency, Gustav Ahlin, Uppsala University, =
Urban Fagerholm, AstraZeneca R&D Sdertlje


More speakers will be announced soon!

Please visit to see the preliminary program





Erik Ahlzn, Project Manager
The Swedish Academy of Pharmaceutical Sciences





Received on Fri Apr 24 2009 - 09:45:48 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: